secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2023-02-08T23:59:59+00:00
Accession:  0001654954-23-001476
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Dermata shareholders approve reverse stock split with ratio up to 1:40
----------------------------------------------------------------------

- Reverse stock split proposal approved: 7,622,928 for, 135,481 against.
- Board authorized to set ratio between 1:2 and 1:40, exact ratio to be determined later.
- Adjournment proposal also approved with 7,681,932 votes for.
- Special meeting held Feb 8, 2023; vote based on 12,321,848 shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495423001476/0001654954-23-001476-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495423001476/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-001476

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer